Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/4/25 16:15 | 6/3/25 | GLUE | Health | BioPrd | Biological Products, (No Diag | Dunn Edmund | MA | O | Principa | S | -9 | 4.45 | 0 | -2 | -8 | 24 | D | ||||||||||||||
10/30/24 16:35 | 10/28/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | S.m | -1,491 | 9.44 | 0 | -158 | -3 | 5,653 | M | |||||||||||||||
9/24/24 16:40 | 9/20/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | S | -7,395 | 6.53 | 0 | -1,133 | -14 | 7,197 | D | |||||||||||||||
9/13/24 18:44 | 9/11/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | S.m | -3,405 | 6.00 | 0 | -567 | -6 | 8,330 | D | |||||||||||||||
7/9/24 16:15 | 7/5/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Dunn Edmund | MA | O | Principa | S | -6 | 3.83 | 0 | -2 | -10 | 14 | D | ||||||||||||||
6/5/24 16:10 | 6/3/24 | GLUE | Health | BioPrd | Biological Products, (No Diag | Dunn Edmund | MA | O | Principa | S | -5 | 4.04 | 0 | -1 | -7 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |